-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Pacific Biosciences Of California, Inc. quarterly/annual Cost of Revenue history and growth rate from 2011 to 2024.
- Pacific Biosciences Of California, Inc. Cost of Revenue for the quarter ending December 31, 2024 was $29.2M, a 40.2% decline year-over-year.
- Pacific Biosciences Of California, Inc. Cost of Revenue for the twelve months ending December 31, 2024 was $117M, a 21% decline year-over-year.
- Pacific Biosciences Of California, Inc. annual Cost of Revenue for 2024 was $117M, a 21% decline from 2023.
- Pacific Biosciences Of California, Inc. annual Cost of Revenue for 2023 was $148M, a 86.4% increase from 2022.
- Pacific Biosciences Of California, Inc. annual Cost of Revenue for 2022 was $79.3M, a 10.6% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)